Browsing Tag

BICX104

BioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104, an…

Eli Pacheco Jul 1, 2022 0

ANAHEIM, CA, June 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance…

Health

BioCorRx Announces Orange County Research Center as Clinical Trial Site for…

Eli Pacheco Feb 14, 2022 0

ANAHEIM, CA, Feb. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance…